Knowledge survey to assess the effectiveness of educational materials among patients prescribed LEMTRADA® (alemtuzumab)

First published 29/05/2020

Last updated 14/03/2024

EU PAS number:

EUPAS35552

Study

Finalised

Documents

Study protocol

Initial protocol

ALEMLC09615_2015-11-30 LEMTRADA_Patients_PROTOCOL 1 7 -WAVE1-final

English (666.14 KB - PDF)View document

Updated protocol

ALEMLC09615_2017-05-08 LEMTRADA_Patients_PROTOCOL 1.8 - WAVE 2

First published: 22/02/2024

English (101.32 KB - PDF)View document

Study results

riskmgtsystem-patient-survey-report

English (3.75 MB - PDF)View document

Study report

Other information

ENCePP Seal

ENCePP Seal documents

Secondary tabs